Bhushan Ghate, 45 of Nagpur has been suffering from Ankylosing spondylitis, an inflammatory disease that can cause bones in the spine to fuse, from the early age of 12. Delayed diagnosis worsened the condition for which he is completely home bound now. He runs patient support groups and helps others with a similar condition in his own way.
Challenges in Diagnosis
I am a good example of delayed diagnosis. When I first felt the symptoms of Ankylosing Spondylitis, it was in 1988-89, when I was…

Tofacitinib (Xeljanz®) is the first of a unique class of oral kinase inhibitors to be FDA approved for the treatment of rheumatoid arthritis (RA). Tofacitinib is a selective inhibitor of Janus kinase (JAK) enzymes. these enzymes mediate signaling for several important cytokines that cause the inflammation in Rheumatoid Arthritic patients.
Changed
06/Sep/2014
Condition